• News

"Biology and Genomic Distinctions in Metastatic Urothelial Carcinoma and Upper Tract Urothelial Cancers "

  • Uro Today
  • New York, NY
  • (August 05, 2019)

Matthew Galsky, MD, director of genitourinary medical oncology at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai discusses research programs and recent findings that drive closer to providing personalized medicine in the treatments in metastatic urothelial carcinoma and upper tract urothelial cancers.

— Matthew Galsky, MD, Director, Genitourinary Medical Oncology, The Tisch Cancer Institute, Professor, Medicine, Hematology and Medical Oncology, Urology, Icahn School of Medicine at Mount Sinai

Learn more